Physician
Regional Health Management Corporation
Regional Health Management Corporation was paid $1.57M by Medicaid between Jan 2018 and Nov 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 64% of everything it billed.
33Billing provider infoREGIONAL HEALTH MANAGEMENT CORPORATION
ANNISTON, AL 36207
ANNISTON, AL 36207
33aNPI1639466584assigned 06/29/2011
33bProvider typeFamily Medicine Physician
28Total paid$1.57M
24GClaims110,835
24DCodes billed77
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Alabama
Rank by total paid#28 of 455
Median peer was paid$57K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,101 | $286K | |
| 2019 | 11,594 | $239K | |
| 2020 | 7,631 | $191K | |
| 2021 | 16,419 | $216K | |
| 2022 | 23,124 | $258K | |
| 2023 | 23,071 | $246K | |
| 2024incomplete | 9,895 | $130K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 64% | 21,380 | 16,907 | $1.01M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 6,627 | 5,577 | $215K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 6.7% | 4,216 | 1,457 | $105K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.6% | 426 | 390 | $41K |
| 80305 | 1.3% | 3,930 | 3,256 | $21K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,543 | 1,076 | $18K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 1,191 | 471 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 135 | 120 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 483 | 454 | $12K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 196 | 150 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,832 | 1,494 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,179 | 1,941 | $10K |
65 more codes
| 83013 | <1% | 228 | $9K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 91 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 697 | $7K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 932 | $6K |
| 43235 | <1% | 53 | $5K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 116 | $5K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 104 | $5K |
| 70220 | <1% | 290 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 825 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 374 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 101 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 116 | $3K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 15 | $2K |
| 94010 | <1% | 153 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,834 | $2K |
| 72100 | <1% | 134 | $2K | |
| 82947 | <1% | 869 | $1K | |
| 86308 | <1% | 345 | $1K | |
| 83014 | <1% | 241 | $1K | |
| 0012A | <1% | 27 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 247 | $1K |
| 99234 | <1% | 26 | $1K | |
| 0011A | <1% | 23 | $920.00 | |
| 76830 | Ultrasound, transvaginal | <1% | 20 | $852.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 549 | $718.86 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 471 | $662.16 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 395 | $653.73 |
| 81002 | <1% | 360 | $620.74 | |
| 82962 | <1% | 257 | $415.78 | |
| 90688 | <1% | 36 | $396.76 | |
| 90756 | <1% | 79 | $387.43 | |
| 94060 | <1% | 26 | $254.48 | |
| 84439 | <1% | 364 | $245.18 | |
| 80053 | Comprehensive metabolic panel | <1% | 27 | $240.00 |
| 81025 | <1% | 104 | $227.20 | |
| 90661 | <1% | 19 | $222.90 | |
| 90686 | <1% | 21 | $193.68 | |
| 81003 | <1% | 86 | $189.10 | |
| 96160 | <1% | 112 | $173.44 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 78 | $160.00 |
| 94726 | <1% | 26 | $147.42 | |
| 94729 | <1% | 26 | $97.38 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 15 | $93.96 |
| 85018 | <1% | 55 | $92.42 | |
| 86580 | <1% | 35 | $78.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $63.11 |
| 82272 | <1% | 26 | $48.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 28 | $12.43 |
| 94250 | <1% | 26 | $8.64 | |
| 1036F | 0% | 9,349 | $0.00 | |
| 3074F | 0% | 5,922 | $0.00 | |
| 3079F | 0% | 2,841 | $0.00 | |
| 3080F | 0% | 1,119 | $0.00 | |
| 1034F | 0% | 1,327 | $0.00 | |
| 3075F | 0% | 1,045 | $0.00 | |
| 3008F | 0% | 11,181 | $0.00 | |
| 1126F | 0% | 136 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 31 | $0.00 |
| 1159F | 0% | 6,740 | $0.00 | |
| 3078F | 0% | 4,907 | $0.00 | |
| 1160F | 0% | 7,537 | $0.00 | |
| 3077F | 0% | 2,361 | $0.00 | |
| 3725F | 0% | 881 | $0.00 | |
| 99080 | 0% | 179 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBASS, LOUIS (VP /CEO)
| Provider | Location | Paid |
|---|---|---|
| The Health Care Authority of the City of Anniston | Anniston, AL | $5.61M |
| The Health Care Authority of the City of Anniston | Anniston, AL | $1.02M |
| The Health Care Authority of the City of Anniston | Jacksonville, AL | $73K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.